erythropoietin (EPO)
Jump to navigation
Jump to search
Introduction
Also see erythropoiesis-stimulating agent
Function
- principal hormone involved in regulation of erythrocyte differentiation & maintenance of circulating erythrocyte mass
Structure
Compartment
Expression
- produced primarily in the peritubular cells of the kidney
- made by interstitial peritubular fibrobasts[8]
- a small amount is produced by the liver
- production of EPO is regulated almost exclusively at the level of transcription
- it is not stored, but excreted immediately.[4]
Pathology
- genetic variation in EPO is associated with susceptbility to microvascular complications of diabetes type 2
Pharmacology
- available as epoetin
Pharmacokinetics
- 10% excreted in the urine
- removal of sialic acid exposes galactose residues subject to degradation by hepatic galactose receptors[4]
1/2life = 4-13 hours
More general terms
More specific terms
Additional terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/P01588.html
- ↑ R&D systems' cytokine source book: erythropoietin http://www.rndsystems.com/molecule_detail.aspx?m=1405
- ↑ Wikipedia; Note: erythropoietin entry http://en.wikipedia.org/wiki/erythropoietin
- ↑ 4.0 4.1 4.2 Yoshimura A, Longmore G, Lodish HF. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature. 1990 Dec 13;348(6302):647-9. PMID: https://www.ncbi.nlm.nih.gov/pubmed/2174515
- ↑ Krantz SB. Erythropoietin. Blood. 1991 Feb 1;77(3):419-34. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/1991159
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 412-13
- ↑ Williams Hematology, 5th ed, Beutler et al (eds), McGraw Hill, NY, 1995, pg 435
- ↑ 8.0 8.1 Medical Knowledge Self Assessment Program (MKSAP) 17, American College of Physicians, Philadelphia 2015